This retrospective chart review provides a profile of an emerging population of vulnerable HIV patients with complex comorbidities. Data were abstracted from all 87 patients admitted in 2008 to Casey House, a community-based hospital dedicated to supportive and palliative care for persons with HIV in Toronto, Canada. We describe patient characteristics, including medical and psychiatric conditions, and use a Venn diagram and case study to illustrate the frequency and reality of co-occurring conditions that contribute to the complexity of patients' health and health care needs. The mean age at admission was 48.9 years (SD 0 10.5). Eighty percent were male. Patients experienced a mean of 5.8 medical comorbidities (SD 0 2.3) and 1.9 psychiatric disorders (lifetime axis I diagnoses). Forty-one patients (47%) experienced cognitive impairment including HIV-associated dementia. Patients were on a mean of 11.8 (SD 0 5.3) medications at admission; 74% were on antiretroviral medications with 55% reporting full adherence. Current alcohol and drug use was common with 54% reporting active use at admission. Our Venn diagram illustrates the breadth of complexity in the clients with 9% of clients living in unstable housing with three or more medical comorbidites and two or more psychiatric diagnoses. Comprehensive HIV program planning should include interventions that can flexibly adapt to meet the multidimensional and complex needs of this segment of patients. Researchers, policymakers and clinicians need to have greater awareness of overlapping medical, psychiatric and psychosocial comorbidities. Inclusion of the needs of these most vulnerable patients in the development of evidence based guidelines is an important step for effectively treating, preventing and planning for the future of HIV/AIDS care.
Introduction
Highly Active Antiretroviral Therapy (HAART) has changed the face of the AIDS epidemic (Palella et al., 1998; Puhan, Van Natta, Palella, Addessi, & Meinert, 2010) . Many now thrive; however, a subset of people living with HIV struggle and contend with high levels of chronic medical, psychiatric and psychosocial morbidity (Rubin, Colen, & Link, 2009; Walley et al., 2008) . Patients such as Abigail (Appendix 1) require ongoing complex care, though this aspect of HIV disease remains scarcely researched and underreported in the literature. Current clinical guidelines are most strongly informed by large randomized controlled trials. Methods used in these trials aim to maximize internal validity, resulting in the under-representation of complex patients (Fortin et al., 2006) . It is important that clinicians, policy makers and researchers understand the breadth and complexity of issues that some people with HIV/AIDS are facing, so that effective resource planning can address the needs of the entire HIV population.
In this paper, we add to the literature by describing the complex and overlapping medical, psychiatric and psychosocial care needs of some of the most vulnerable patients living with HIV disease. We conducted data abstraction through retrospective chart review of all patients admitted to a community-based HIV/AIDS hospital during the course of 1 year.
Methods

Research setting
Casey House is a 13-bed sub-acute hospital providing both in-patient and home care services to people living with HIV/AIDS. Individuals with HIV may be admitted for sub-acute, palliative or respite care, provided by an inter-professional team including physicians, nurses, rehabilitation therapists and social workers. 
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Research methods and data analysis
We employed an in-depth retrospective chart review to collect data on patient demographics, self-reported substance use, medical and psychiatric history. Cognitive impairment was diagnosed according to the nosology for HIV-Associated Neurocognitive Disorders (Antinori et al., 2007) . Data were analysed in SPSS version 17.0.
Data are from all 87 patients admitted to Casey House between 1 January and 31 December 2008. Seventy-four patients were admitted once, 13 patients were admitted on multiple occasions. Only first admission data are reported. Ethical approval was obtained through the St. Michael's Hospital Research Ethics Board.
Results
Participant characteristics
Patient demographics and medical and psychiatric history are summarized in Table 1 and Table 2 . The majority of patients was male (n070; 80.5%) and patients' mean age was 48.9 years (SD 010.5). About half of the patients identified as homosexual (n 045; 51.7%). Twelve patients (13.8%) reported living on the street or in a shelter at the time of admission and five patients (5.7%) were under-housed, staying with friends or family.
Hospital stay
Twenty-three patients (26.4%) were admitted as a planned 14-day respite stay while the remaining patients entered through a general admission (mean stay 046.6 days (SD 049.1)). Patients could have multiple reasons for admission (summarized in Table  3 ): the most common being for supportive care with a medical focus (86.2%) (i.e., failure to thrive, recovery from acute medical illness) and HAART adherence support (20.7%).
Seventeen of the patients admitted in 2008 died at Casey House (19.5%). The remaining patients were discharged to various locations including home (n 035; 40.2%), hospital (n 014; 16.1%), supportive housing (n 014; 16.1%), community shelters (n 04; 4.6%) and nursing homes (n 02; 2.3%).
Medical history
Patients had been living with HIV for an average of 14.6 years (SD 07.6). Forty-eight patients (57.8%) had CD4 counts below 200 cells/ml. Ten patients (11.5%) did not have a primary care physician.
At admission, patients were taking an average of 11.8 medications (SD 0 5.3). Seventy-four percent were on HAART (n 064); just over half of these patients reported being adherent (n035; 54.7%). On average, patients experienced 5.8 (SD 02.3) medical co-morbidities, the most common being AIDS-defining opportunistic infections (n 045; 51.7%), respiratory disease (n039; 44.8%) and liver disease (n 026; 29.9%).
Psychiatric history, neurocognitive status and substance use
Psychiatric comorbidity was significant with a group mean of 1.9 lifetime axis I diagnoses (SD 0 1.1). The most common psychiatric disorders were substance 
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substances, most commonly cocaine (n 020; 23.0%) and marijuana (n014; 11.5%).
Patient complexity
We used a Venn diagram to demonstrate the coexistence of complicating conditions (Figure 1 ). We defined three variables of complexity: medical complexity, psychiatric complexity and housing instability. Medical complexity is defined by having three or more medical comorbidities. Psychiatric complexity is defined as having two or more lifetime Axis I diagnoses (which includes substance misuse and cognitive disorders). Housing instability was defined as living on the street, in a shelter or with family or friends. Three patients (3.4%) did not have any of these complexities. Eighty patients (92%) had two or more Axis I diagnoses, 30 patients (34.5%) had three or more medical comorbidities and 17 patients (19.5%) had unstable housing. Eight patients (9.2%) experienced all three complexity variables.
Discussion
This chart review provides a profile of issues experienced by a segment of the evolving HIV-positive population with high care needs in Toronto. These patients are too unwell to manage independently and require a community-based flexible alternative to acute care hospitalizations. Appendix 1 provides a case example of the context and care provided. 
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Today, treatment with antiretroviral therapies enables the majority of the HIV-positive population in developed countries to live longer, healthier lives. However, we highlight a vulnerable population that is unable to optimally benefit from existing therapies. Twenty percent of our patients died during their stay illuminating the fact that people with HIV disease continue to contend with early mortality. In addition to HIV disease and considerable psychosocial challenges, patients had multiple medical comorbidities, were taking, on average, more than 11 medications, and almost half had cognitive impairment.
The co-occurrence of medical, psychiatric and psychosocial complexities in Casey House patients was significant, as illustrated in our Venn diagram. Our findings are analogous to those reported from an HIV-infected veterans cohort. Kilbourne et al. (2001) demonstrated significant overlap of conditions when examining depressive symptoms, at-risk alcohol or illicit drug use, and two or more general comorbidities. These results emphasize the need to both, identify coexisting conditions and to improve our understanding of how they influence standard treatment protocols. As Parekh, Goodman, Gordon, Koh, and HHS Interagency Workgroup on Multiple Chronic Conditions (2011) recommended, this includes improving the external validity of clinical trials and incorporating the issue of multi-morbidity in clinical guidelines. Our results also highlight the need for improved coordination of medical and psychiatric care as well as an integration of psychosocial, recovery-oriented addictions and harm reduction services, to enable all patients to benefit from the advances in HIV/AIDS medicine.
Our report shares many findings with a study examining medical and psychiatric comorbidities in HIV-positive patients cared for between 1995 and 1998, at an AIDS designated long-term care facility in New Haven, USA (Selwyn et al., 2000) . In their sample of patients with late stage HIV disease, they also found high rates of medical illness, HIV dementia (32%) and psychiatric illness (44%). As these authors noted, with the effectiveness of HAART, people are living longer with HIV and a growing number experience morbidity, marginalization and disability. Our findings, from 10 years later in the HIV epidemic, echo this notion and demonstrate the need for interventions that can flexibly support these patients.
Limitations and future directions
Our study provides some of the missing context to the HIV/AIDS literature, focusing on complex patients in Toronto, Canada. We acknowledge that this study has important limitations. Our ability to explore clinical outcomes is limited by issues associated with chart reviews including the lack of standardized diagnoses. The use of self-reports for determining alcohol and substance use likely resulted in an underestimation of use. The complexity and often disjointed care in multiple centres, common to this population, provided additional barriers to obtaining both health and care variables. However, the importance of this study is strengthened by the inclusion of all patients seen over a 12-month period at a community-based HIV/AIDS hospital. Although stigma remains a barrier for some to seek treatment, this research design allowed us to capture marginalized and medically complex individuals who are often not represented in prospective studies.
Future longitudinal research should include a holistic view of individuals with HIV, addressing their medical, psychiatric and social needs, and the various interactions between them. We must make the effort to include complex patients in research so we can make evidence-based decisions. Guidelines based solely on randomized controlled trials of healthier patients with HIV/AIDS may fail to address the complex care needs of the most vulnerable patients. Policy makers must strive to make just allocation of resources so that needs of patients such as Abigail may be met.
